Toxicology Research and Application最新文献

{"title":"Soil chemical evaluation and power plant ash impact on chemical properties of Salix alba L. (Fam. Salicaceae): The impact of bioaccumulation","authors":"Demush Bajraktari, B. Petrovska, Lulzim Zeneli, A. Dimitrovska, Z. Kavrakovski","doi":"10.1177/2397847320924849","DOIUrl":"https://doi.org/10.1177/2397847320924849","url":null,"abstract":"Plants grown under contaminated conditions exhibit differences in metal absorption, accumulation, and transportation, and these differences are seen in different plant parts. Metal content in the soil and bark samples collected next to the Sitnica river, which passes through the industrial area of thermal power plants in Kosovo, was measured by inductively coupled plasma optical emission spectrometry. The total metal concentration in willow bark collected from the polluted area of Obilic, Kosovo, ranged 5260–22,280 mg/kg for calcium (Ca), 840–1680 mg/kg for magnesium (Mg), 66.79–910.75 mg/kg for iron (Fe), 5.09–28.66 mg/kg for copper (Cu), 56.39–140.94 mg/kg for zinc (Zn), 19.68–392.75 mg/kg for manganese (Mn), 6.49–10.09 mg/kg for nickel (Ni), 0.10–4.49 mg/kg for cadmium (Cd), 0.85–1.89 mg/kg for chromium (Cr), and 67.79–94.77 mg/kg for aluminum (Al). Data analysis indicated that correlation between trace elements in the soil and willow bark samples varied with the highest observed in Ni(s)/Zn(p) and Fe(s)/Ca(p) followed by Fe(s)/Mg(p), Al(s)/Ca(p), Cr(s)/Mg(p), Cr(s)/Cu(p), Ni(s)/Ni(p), Cu(s)/Ca(p), and Cu(s)/Zn(p). Correlations among trace elements within willow bark samples varied. The correlation between Cr and Al concentration was the highest, followed by that between Ni and Al. A significantly strong correlation was observed between Al and Fe, Ni and Cr, Cr and Fe, Ni and Fe, and Ca and Mg. The highest transfer factor was established in Zn, followed by Cu > Ni > Cr > Al > Fe.","PeriodicalId":23155,"journal":{"name":"Toxicology Research and Application","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78992952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is cannabidiol hepatotoxic or hepatoprotective: A review","authors":"S. Stohs, S. Ray","doi":"10.1177/2397847320922944","DOIUrl":"https://doi.org/10.1177/2397847320922944","url":null,"abstract":"Questions have been raised regarding the potential hepatotoxicity of cannabidiol (CBD). Conversely, several animal studies have demonstrated the hepatoprotective effects of CBD against bile duct ligation, cocaine, thioacetamide, alcohol, and several other chemicals. This review summarizes the current literature concerning the hepatic effects of CBD in humans and animals. Based on the available data, it may be concluded that there is a low probability of serious hepatotoxicity at the high therapeutic doses that are used and a much lower risk of adverse hepatic effects and a potential for hepatoprotection effects at the lower doses commonly used in dietary supplements and food products. However, a detailed safety study in rats using highly purified CBD rather than enriched Cannabis extracts is needed, enabling the determination of hepatic as well as other tissue effects and potential margin of safety.","PeriodicalId":23155,"journal":{"name":"Toxicology Research and Application","volume":"43 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78454599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Olive oil limited motor disruption and neuronal damage in parkinsonism induced by MPTP administration","authors":"E. Farfán-García, Antonio Abad-García, A. Alatorre, Teresa Pérez-Capistran, E. Querejeta, M. Soriano-Ursúa","doi":"10.1177/2397847320922939","DOIUrl":"https://doi.org/10.1177/2397847320922939","url":null,"abstract":"Some vegetable oils show beneficial effects in modulating neurodegeneration; in this work, we evaluated the therapeutic potential of corn and olive oils against neurodegenerative processes using the acute parkinsonism murine model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in C57BL6 mice. The effects of corn and olive oils were quantified by the performance of mice in the open field and rotarod, and grasp strength tests and neuronal survival in the substantia nigra and striatum were determined by immunohistochemistry. Extra-virgin olive oil decreased the toxicity induced by MPTP administration judged by the performance in the behavioral motor tests and the number of total neurons in the analyzed brain regions. In contrast, corn oil only produced discrete changes in the behavioral and histological evaluations. Despite the numerous benefits of olive oil, its active substances that confer desirable effects and their mechanism of action remain unclear. Our observations can help to understand the ameliorative effects of some natural oils on neurodegeneration induced by some toxins, particularly the attenuation of neural damage related to toxin-induced parkinsonism or other pathologies that comprise neuronal death and motor disruption.","PeriodicalId":23155,"journal":{"name":"Toxicology Research and Application","volume":"72 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84159439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Toxicological assessment of β-galactosidase shows no adverse effects in vivo and in vitro","authors":"J. Symonds, T. Fujita, S. Aoki, Kazuma Shiota, C. Kruger","doi":"10.1177/2397847320908776","DOIUrl":"https://doi.org/10.1177/2397847320908776","url":null,"abstract":"A safety assessment for β-galactosidase derived from Aspergillus oryzae (GODO-FAL) was performed. The test article was a concentrated, purified β-galactosidase diluted in glycerin and water with an activity of 10,000 U/mL. A series of genotoxicology tests including micronucleus assay, chromosome aberration assay, and reverse mutagenesis (Ames) assay confirmed that GODO-FAL was not clastogenic or mutagenic at any of the concentrations used, up to 2000 µg/mL for the chromosome aberration assay and 5000 mg per plate in the Ames assay. GODO-FAL was not toxic in acute, repeated oral toxicity, and sub-chronic toxicity assays in Sprague–Dawley rats at any dose used, up to 2000 mg/kg/day. Based on results from the subchronic toxicology assay, the no observed adverse effects level for GODO-FAL was at least 2000 mg/kg/day.","PeriodicalId":23155,"journal":{"name":"Toxicology Research and Application","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81495161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Meldonium: Pharmacological, toxicological, and analytical aspects","authors":"D. G. Berlato, A. V. Bairros","doi":"10.1177/2397847320915143","DOIUrl":"https://doi.org/10.1177/2397847320915143","url":null,"abstract":"Meldonium is the active molecule from Mildronate® with similar chemical structure to an amino acid, and it is known as (3-(2,2,2-trimethylhydrazine) propionate) (CAS 76144-81-5). This pharmaceutical substance is approved in Eastern Europe for cerebral and myocardial ischemia and has been on the World Doping Association’s banned substances list since January 2016. The goal of this review is to relate the use of meldonium as a doping agent, considering its pharmacological, toxicological, and analytical aspects. This review is based on the scientific literature from digital platforms. The main mechanism of action of meldonium is based on a decrease in l-carnitine levels and increase of peroxisomes activity in the cytosol. Females were more susceptible to the substance in animal experiments for toxicological tests. There is currently no report in the scientific literature about acute or chronic intoxication cases by meldonium in humans. Based on the literature findings, meldonium showed ergogenic effect in animals and human volunteers. For anti-doping analysis, urine is the biological matrix of choice, and dilute-and-shoot is the most common sample treatment in addition to liquid chromatography–mass spectrometry analysis. Other approaches could be used to determine meldonium levels, mainly for screening tests, such as l-carnitine or gamma-butyrobetaine levels.","PeriodicalId":23155,"journal":{"name":"Toxicology Research and Application","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76172062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Juvenile toxicity study of Gossence™ (galactooligosaccharides) in Sprague Dawley rats","authors":"M. Jain, Moninder Kaur, Deepika P Tiwari, C. Vishwanath, Nataraju Javaregowda, Govind Chandrayan, Prabhakar Y Bhoite, M. Krishnappa, A. Dubey","doi":"10.1177/2397847320913213","DOIUrl":"https://doi.org/10.1177/2397847320913213","url":null,"abstract":"Gossence™ (galactooligosaccharide; GOS) is a prebiotics and used as one of the major constituents in infant milk formulas that act as a functional food. Gossence is manufactured by Tata Chemicals Ltd, India, through a patented process of biotransformation of lactose. A toxicology study in juvenile rats was carried out to assess the safety profile of Gossence intended for pediatric population. The objective of this study is to assess the potential systemic toxicity of Gossence when administered through gavage at dose levels of 1000, 2000, or 5000/3000 mg/kg/day (equivalent to 1347, 2694, and 6735/4041 mg/kg/day of GOS, respectively) to juvenile Sprague Dawley rats from postnatal day (PND) 4 to PND 52 (i.e. total 49 days of dosing period). A separate group of animals were treated with vehicle (purified Milli Q water) for a similar duration. The following parameters were evaluated during the study period: morbidity/mortality check, clinical signs, body weights, body weight changes, food consumption, functional observational battery, motor activity, postnatal developmental observations, hematology, clinical chemistry, urinalysis, organ weight, gross pathology, and histopathology. During dosing phase, the high-dose group, 5000 mg/kg/day, was reduced to 3000 mg/kg/day (equivalent to 4041 mg/kg/day dose of GOS) from day 16 (PND 19) onward, due to clinical signs of watery feces and yellow color stains at urogenital region and mortality in two animals on day 15 (PND 18) of the study. Time-weighted average dose for 5000 mg/kg/day was equivalent to 3600 mg/kg/day. No further deaths or clinical signs were noticed in animals at 3000 mg/kg/day from day 18 (PND 21) of dosing phase to until terminal euthanization. At the terminal euthanization, there were no test item-related gross changes observed in all surviving rats except for, an increased cecum size in some of the rats at 5000/3000 mg/kg/day, which correlated with the increased weights of cecum with contents during organ weight recording, but this had no correlating light microscopic changes during histological examination. The cecal enlargement was completely recovered following the 14-day recovery period. The no-observedadverse-effect level is 3000 mg/kg/day for Gossence, which is equivalent to 4041 mg/kg/day of GOS in both sexes.","PeriodicalId":23155,"journal":{"name":"Toxicology Research and Application","volume":"40 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89578203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Regional differences in airway susceptibility to cigarette smoke: An investigational case study of epithelial function and gene alterations in in vitro airway epithelial three-dimensional cultures","authors":"K. Matsumura, Takeshi Kurachi, S. Ishikawa, N. Kitamura, S. Ito","doi":"10.1177/2397847320911629","DOIUrl":"https://doi.org/10.1177/2397847320911629","url":null,"abstract":"Cigarette smoke (CS) is a risk factor contributing to lung remodeling in chronic obstructive pulmonary disease (COPD). COPD is a heterogeneous disease because many factors contribute in varying degrees to the resulting airflow limitations in different regions of the respiratory tract. This heterogeneity makes it difficult to understand mechanisms behind COPD development. In the current study, we investigate the regional heterogeneity of the acute response to CS exposure between large and small airways using in vitro three-dimensional (3D) cultures. We used two in vitro 3D human airway epithelial tissues from large and small airway epithelial cells, namely, MucilAir™ and SmallAir™, respectively, which were derived from the same single healthy donor to eliminate donor differences. Impaired epithelial functions and altered gene expression were observed in SmallAir™ exposed to CS at the lower dose and earlier period following the last exposure compared with MucilAir™. In addition, severe damage in SmallAir™ was retained for a longer duration than MucilAir™. Transcriptomic analysis showed that although well-known CS-inducible biological processes (i.e. inflammation, cell fate, and metabolism) were disturbed with consistent activity in both tissues exposed to CS, we elucidated distinctively regulated genes in only MucilAir™ and SmallAir™, which were mostly related to catalytic and transporter activities. Our findings suggest that CS exposure elicited epithelial dysfunction through almost the same perturbed pathways in both airways; however, they expressed different genes related to metabolic and transporter activities in response to CS exposure which may contribute to cytotoxic heterogeneity to the response to CS in the respiratory tract.","PeriodicalId":23155,"journal":{"name":"Toxicology Research and Application","volume":"48 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74677406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Statistical treatment of cytotoxicity in Ames bacterial reverse mutation assays can provide additional structure–activity relationship information","authors":"Carr J. Smith, T. Perfetti","doi":"10.1177/2397847320911631","DOIUrl":"https://doi.org/10.1177/2397847320911631","url":null,"abstract":"The bacterial reverse mutation assay, that is, the Ames test, measures mutations that reverse the inactivation of a gene involved in the synthesis of either histidine in Salmonella bacteria or tryptophan in Escherichia coli. The classic dose–response curve of an Ames assay plots number of reverse mutations (“revertants”) on the y-axis versus dose of the test chemical on the x-axis. Frequently, the dose–response curve resembles a parabola with a linear initial slope resulting from the accumulation of mutations, which transitions to a downward curvature resulting from cell killing (cytotoxicity) at increasingly higher doses of the test chemical. For regulatory purposes, a positive Ames test is usually considered as induction of twice the number of reverse mutations above background levels. For research purposes, the potency of the mutagenic response can be calculated from measuring the initial slope of the mutagenic response. This initial slope can be calculated in a manner that disentangles the downward pull on the initial slope value provided by the initiation of cytotoxicity. For a dose–response curve resembling a parabola, both the initial positive slope representing mutagenicity and the secondary negative slope representing cytotoxicity can be calculated from the same dose–response curve. The Ames test is the most commonly conducted genotoxicity assay. When a series of molecular congeners are assayed in the Ames test for mutagenicity, additional consideration of the cytotoxicity can provide important structure–activity relationship information.","PeriodicalId":23155,"journal":{"name":"Toxicology Research and Application","volume":"82 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90511106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Insecticidal activity of Lantana camara extract oil on controlling maize grain weevils","authors":"A. Ayalew","doi":"10.1177/2397847320906491","DOIUrl":"https://doi.org/10.1177/2397847320906491","url":null,"abstract":"Postharvest losses are known to be one of the serious constraints upon food security among farmers poor resource in Africa. The use of botanical insecticide in pest management during storage against weevils is often encouraged because synthetic insecticides produce multiple side effects on human and environment. In this study, the insecticidal property of methanol, ethanol, and ethyl acetate extracts of Lantana camara leaf oil and powder for controlling maize weevils, Sitophilus zeamais, was studied. Gas chromatography–mass spectrometry and Fourier transform infrared spectroscopy (FTIR) were used to identify the chemical composition and functional group of solvent extract, respectively. Adult weevil repellency and mortality were studied by the effect of oil concentration at 0% (w/w), 2% (w/w), 3% (w/w), 5% (w/w), 7% (w/w), and 10% (w/w). Repellency effect was also conducted at 6, 12, and 24 h. The number of weevil death increased significantly as exposed time was increased. The extracted oil by the three-solvent fraction had direct repellent and toxic effect to the weevil. From all treatment applied, extracted by methanol fraction had showed highest percentage mortality (74%). The lowest mortality rate was observed in ethyl acetate extract (26%) at 2% (w/w) concentration. The effect of leaf powder and extracted oil on repellency and mortality for insects was due to the presence of bioactive and phytochemical molecules such as Phytol, Pyrroline, Paromomycin, Pyrrolizin, and 1-Eicosano. It was concluded that both L. camara leaf powder and extract oil can be used for the protection of stored maize from infestation S. zeamais.","PeriodicalId":23155,"journal":{"name":"Toxicology Research and Application","volume":"63 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83068398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating the correlation between serum vitamin B12 levels and various haematologic indices among metformin-treated type 2 diabetic patients: A prospective analytical study","authors":"O. Fasipe, S. Owhin, T. Adaja, M. O. Ojo, P. Akhideno, A. Enikuomehin","doi":"10.1177/2397847319900560","DOIUrl":"https://doi.org/10.1177/2397847319900560","url":null,"abstract":"Background: Metformin-induced vitamin B12 deficiency state or metformin-induced hypocobalaminemia is gradually becoming an epidemic among diabetic patients on moderate-to-high doses of metformin or those diabetic patients on metformin for a long period of time. The potential effect of chronic metformin pharmacotherapy to cause vitamin B12 deficiency with abnormalities in haematologic indices and central/peripheral neuropathy has been widely reported. Long-term usage of metformin has been reported to be associated with intestinal malabsorption of vitamin B12 culminating in vitamin B12 deficiency with likely associated haematologic abnormalities (including macro-ovalocytic anaemia and immune dysfunctioning due to hypersegmentation of polymorphonuclear leukocytes), central/peripheral neuropathy and manifestation of biochemical derangements such as elevated homocysteine and methyl malonate levels. Aim: This study aimed to determine the correlation between serum vitamin B12 levels and various haematologic indices among metformin-treated type 2 diabetic patients in a clinical practice setting with the rational purpose of alleviating/preventing the associated derangements. Materials and Methods: This was a case-control, prospective, analytical, observational study of 200 adult participants (100 per group) attending the Endocrinology Out-patients Clinic of Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria. For each participant, serum vitamin B12 level was determined using a vitamin B12 immunoassay technique, while the corresponding complete blood count was done using PCE-210N autohaematology analyser. Data were presented using tables and figures. Chi-square test was used to compare categorical variables, Student t-test was used in comparing means of continuous variables, while Pearson’s correlation study was done to determine the existence of any statistically significant correlation(s) between the serum vitamin B12 levels and various haematologic indices among the participants. Results: Approximately 41% versus 20% of the metformin-treated and metformin-naive diabetic patients, respectively, had frank vitamin B12 deficiency. There was a statistical difference between the total serum vitamin B12 levels in male and female diabetic patients with p = 0.048. Also, statistically significant differences existed with respect to mean corpuscular volume (MCV), mean corpuscular haemoglobin and total white blood cells count among the metformin-treated and metformin-naive diabetic patients. Furthermore, a statistically significant weak positive correlation existed between pack cell volume (PCV) and serum vitamin B12 level (r = +0.148, p = 0.037), but a statistically significant weak negative correlation existed between MCV and serum vitamin B12 level (r = −0.245, p = 0.0001). In addition, the test for associations between the serum vitamin B12 categorization status or metformin exposure status and the peripheral neuropathy components assessment revealed ","PeriodicalId":23155,"journal":{"name":"Toxicology Research and Application","volume":"35 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87216027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}